Skip to main content
Erschienen in: Annals of Surgical Oncology 4/2008

01.04.2008 | Melanomas

Compliance with Melanoma Treatment Guidelines in a Community Teaching Hospital: Time Trends and Other Variables

verfasst von: Jennifer L. Erickson, MD, Josè M. Velasco, MD, Tina J. Hieken, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 4/2008

Einloggen, um Zugang zu erhalten

Abstract

Background

Variation in the surgical treatment of melanoma occurs despite efforts to standardize care. This may lead to morbidity, inaccurate staging, and poor outcomes, or it may be cost ineffective. The purpose of our study was to evaluate our institutional compliance with National Comprehensive Cancer Network (NCCN) melanoma treatment guidelines.

Methods

We studied 252 clinically node-negative melanoma patients identified from our cancer registry. Treatment data were confirmed by individual review of pathology and operative reports.

Results

Documented margins of excision conformed to NCCN guidelines in 87% of Tis–T1 tumors and 60% of T2–T4 tumors. Lymph node staging was performed in 11% of T1a, 64% of T1b, 74% of T2, 63% of T3, and 47% of T4 patients. Treatment by a surgical oncologist achieved margin and lymph node compliance in 95% and 92% of cases versus other practitioners in 38% and 67%, respectively (P < .0001). Documented compliance with margin guidelines improved from 46% to 73% for the years 1995 to 1999 versus 2000 to 2004 (P < .0001) and for lymph node staging and treatment from 74% to 84% (P = .04). Other factors associated with greater adherence to NCCN guidelines were patient age <80 years, upper extremity tumors, and thinner tumors (all P < .05).

Conclusions

Our data suggest that our compliance with NCCN melanoma treatment guidelines was suboptimal. Treatment directed by a surgical oncologist showed the highest rate of adherence to national standards. Further investigation is needed to determine the effect of this on patient outcomes and how best to provide high-quality care to the greatest number of melanoma patients.
Literatur
1.
Zurück zum Zitat Jamal A, Siegel R, Ward E, et al. Cancer Statistics, 2007. CA Cancer J Clin 2007;57:43–66CrossRef Jamal A, Siegel R, Ward E, et al. Cancer Statistics, 2007. CA Cancer J Clin 2007;57:43–66CrossRef
2.
Zurück zum Zitat Veronesi U, Cascinelli N. Narrow excision (1-cm margin): a safe procedure for thin cutaneous melanoma. Arch Surg 1991;126:438–41PubMed Veronesi U, Cascinelli N. Narrow excision (1-cm margin): a safe procedure for thin cutaneous melanoma. Arch Surg 1991;126:438–41PubMed
3.
Zurück zum Zitat Cohn-Cedermark G, Rutqvist LE, Andersson R, et al. Long term results of a randomized study by the Swedish Melanoma Study Group on 2-cm versus 5-cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8–2.0 mm. Cancer 2000;89:1495–501PubMedCrossRef Cohn-Cedermark G, Rutqvist LE, Andersson R, et al. Long term results of a randomized study by the Swedish Melanoma Study Group on 2-cm versus 5-cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8–2.0 mm. Cancer 2000;89:1495–501PubMedCrossRef
4.
Zurück zum Zitat Balch CM, Soong SJ, Smith T, et al. Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1–4 mm melanomas. Ann Surg Oncol 2001;8:101–8PubMed Balch CM, Soong SJ, Smith T, et al. Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1–4 mm melanomas. Ann Surg Oncol 2001;8:101–8PubMed
5.
Zurück zum Zitat Khayat D, Rixe O, Martin G, et al. Surgical margins in cutaneous melanoma (2 cm versus 5 cm for lesions measuring less than 2.1-mm thick): long-term results of a large European multicentric phase III study. Cancer 2003;97:1941–6PubMedCrossRef Khayat D, Rixe O, Martin G, et al. Surgical margins in cutaneous melanoma (2 cm versus 5 cm for lesions measuring less than 2.1-mm thick): long-term results of a large European multicentric phase III study. Cancer 2003;97:1941–6PubMedCrossRef
6.
Zurück zum Zitat Thomas JM, Newton-Bishop J, A’Hern R, et al. Excision margins in high-risk malignant melanoma. N Engl J Med 2004;350:757–66PubMedCrossRef Thomas JM, Newton-Bishop J, A’Hern R, et al. Excision margins in high-risk malignant melanoma. N Engl J Med 2004;350:757–66PubMedCrossRef
7.
Zurück zum Zitat McKinnon JG, Starritt EC, Scolyer RA, et al. Histopathologic excision margin affects local recurrence rate: analysis of 2681 patients with melanomas ≤2 mm thick. Ann Surg 2005;241:326–33PubMedCrossRef McKinnon JG, Starritt EC, Scolyer RA, et al. Histopathologic excision margin affects local recurrence rate: analysis of 2681 patients with melanomas ≤2 mm thick. Ann Surg 2005;241:326–33PubMedCrossRef
8.
Zurück zum Zitat Thompson JF, Scolyer RA, Uren RF. Surgical management of primary cutaneous melanoma: excision margins and the role of sentinel lymph node examination. Surg Oncol Clin N Am 2006;15:301–18PubMedCrossRef Thompson JF, Scolyer RA, Uren RF. Surgical management of primary cutaneous melanoma: excision margins and the role of sentinel lymph node examination. Surg Oncol Clin N Am 2006;15:301–18PubMedCrossRef
9.
Zurück zum Zitat Lens MB, Dawes M, Goodacre T, et al. Excision margins in the treatment of primary cutaneous melanoma: a systematic review of randomized controlled trials comparing narrow vs wide excision. Arch Surg 2002;137:1101–6PubMedCrossRef Lens MB, Dawes M, Goodacre T, et al. Excision margins in the treatment of primary cutaneous melanoma: a systematic review of randomized controlled trials comparing narrow vs wide excision. Arch Surg 2002;137:1101–6PubMedCrossRef
10.
Zurück zum Zitat Balch CM, Urist MM, Karakousis CP, et al. Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Ann Surg 1993;218:262–9PubMedCrossRef Balch CM, Urist MM, Karakousis CP, et al. Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Ann Surg 1993;218:262–9PubMedCrossRef
11.
Zurück zum Zitat Hieken TJ. The role of sentinel node biopsy in skin cancer (2nd edition). In: eMedicine Clinical Knowledge Base, Dermatology. Updated May 2006. Available at: http://www.emedicine.com. Accessed March 1, 2007 Hieken TJ. The role of sentinel node biopsy in skin cancer (2nd edition). In: eMedicine Clinical Knowledge Base, Dermatology. Updated May 2006. Available at: http://​www.​emedicine.​com. Accessed March 1, 2007
12.
Zurück zum Zitat Morton DL, Thompson JF, Cochran JF, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 2006;355:1307–15PubMedCrossRef Morton DL, Thompson JF, Cochran JF, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 2006;355:1307–15PubMedCrossRef
14.
Zurück zum Zitat Haigh PI, Urbach DR. Underuse of wide excision for primary cutaneous melanoma in the United States. Am Surg 2004;70:942–6PubMed Haigh PI, Urbach DR. Underuse of wide excision for primary cutaneous melanoma in the United States. Am Surg 2004;70:942–6PubMed
15.
Zurück zum Zitat Cormier JN, Xing Y, Ding M, et al. Population-based assessment of surgical treatment trends for patients with melanoma in the era of sentinel lymph node biopsy. J Clin Oncol 2005;23:6054–62PubMedCrossRef Cormier JN, Xing Y, Ding M, et al. Population-based assessment of surgical treatment trends for patients with melanoma in the era of sentinel lymph node biopsy. J Clin Oncol 2005;23:6054–62PubMedCrossRef
16.
Zurück zum Zitat Sitzenberg KB, Thomas NE, Beskow LM, et al. Population-based analysis of lymphatic mapping and sentinel lymphadenectomy utilization for intermediate thickness melanoma. J Surg Oncol 2006;93:100–8CrossRef Sitzenberg KB, Thomas NE, Beskow LM, et al. Population-based analysis of lymphatic mapping and sentinel lymphadenectomy utilization for intermediate thickness melanoma. J Surg Oncol 2006;93:100–8CrossRef
17.
Zurück zum Zitat Scott JD, McKinley BP, Bishop A, et al. Treatment and outcomes of melanoma with a Breslow’s depth greater than or equal to one millimeter in a regional teaching hospital. Am Surg 2005;71:198–201PubMed Scott JD, McKinley BP, Bishop A, et al. Treatment and outcomes of melanoma with a Breslow’s depth greater than or equal to one millimeter in a regional teaching hospital. Am Surg 2005;71:198–201PubMed
18.
Zurück zum Zitat Lens MB, Dawes M. Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol 2004;150:179–85PubMedCrossRef Lens MB, Dawes M. Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol 2004;150:179–85PubMedCrossRef
Metadaten
Titel
Compliance with Melanoma Treatment Guidelines in a Community Teaching Hospital: Time Trends and Other Variables
verfasst von
Jennifer L. Erickson, MD
Josè M. Velasco, MD
Tina J. Hieken, MD
Publikationsdatum
01.04.2008
Verlag
Springer-Verlag
Erschienen in
Annals of Surgical Oncology / Ausgabe 4/2008
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-007-9789-6

Weitere Artikel der Ausgabe 4/2008

Annals of Surgical Oncology 4/2008 Zur Ausgabe

Letter to the Editor

In Reply

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.